Abstract
In this issue of Blood, Gokbudget et al provide strong evidence that immunotherapy with blinatumomab can eliminate residual chemotherapy-resistant B-c......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
